These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 14988236

  • 1. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.
    Gaster M, Rustan AC, Aas V, Beck-Nielsen H.
    Diabetes; 2004 Mar; 53(3):542-8. PubMed ID: 14988236
    [Abstract] [Full Text] [Related]

  • 2. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes.
    Gaster M, Rustan AC, Beck-Nielsen H.
    Diabetes; 2005 Mar; 54(3):648-56. PubMed ID: 15734839
    [Abstract] [Full Text] [Related]

  • 3. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.
    Gaster M, Beck-Nielsen H.
    Biochim Biophys Acta; 2006 Jan; 1761(1):100-10. PubMed ID: 16442843
    [Abstract] [Full Text] [Related]

  • 4. Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid.
    Wensaas AJ, Rustan AC, Just M, Berge RK, Drevon CA, Gaster M.
    Diabetes; 2009 Mar; 58(3):527-35. PubMed ID: 19066312
    [Abstract] [Full Text] [Related]

  • 5. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
    Kase ET, Feng YZ, Badin PM, Bakke SS, Laurens C, Coue M, Langin D, Gaster M, Thoresen GH, Rustan AC, Moro C.
    Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
    [Abstract] [Full Text] [Related]

  • 6. The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubes.
    Gaster M, Beck-Nielsen H.
    Biochim Biophys Acta; 2004 Sep 06; 1690(1):85-91. PubMed ID: 15337174
    [Abstract] [Full Text] [Related]

  • 7. Reduced incorporation of fatty acids into triacylglycerol in myotubes from obese individuals with type 2 diabetes.
    Sparks LM, Bosma M, Brouwers B, van de Weijer T, Bilet L, Schaart G, Moonen-Kornips E, Eichmann TO, Lass A, Hesselink MKC, Schrauwen P.
    Diabetes; 2014 May 06; 63(5):1583-1593. PubMed ID: 24487026
    [Abstract] [Full Text] [Related]

  • 8. Long-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects.
    Just M, Faergeman NJ, Knudsen J, Beck-Nielsen H, Gaster M.
    Biochim Biophys Acta; 2006 Jul 06; 1762(7):666-72. PubMed ID: 16815692
    [Abstract] [Full Text] [Related]

  • 9. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
    Ortenblad N, Mogensen M, Petersen I, Højlund K, Levin K, Sahlin K, Beck-Nielsen H, Gaster M.
    Biochim Biophys Acta; 2005 Jun 30; 1741(1-2):206-14. PubMed ID: 15894466
    [Abstract] [Full Text] [Related]

  • 10. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
    Kitzmann M, Lantier L, Hébrard S, Mercier J, Foretz M, Aguer C.
    Biochim Biophys Acta; 2011 Apr 30; 1812(4):423-30. PubMed ID: 21172433
    [Abstract] [Full Text] [Related]

  • 11. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
    Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ.
    J Appl Physiol (1985); 2006 May 30; 100(5):1467-74. PubMed ID: 16357064
    [Abstract] [Full Text] [Related]

  • 12. Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells.
    Aas V, Rokling-Andersen MH, Kase ET, Thoresen GH, Rustan AC.
    J Lipid Res; 2006 Feb 30; 47(2):366-74. PubMed ID: 16301737
    [Abstract] [Full Text] [Related]

  • 13. Myotubes from severely obese type 2 diabetic subjects accumulate less lipids and show higher lipolytic rate than myotubes from severely obese non-diabetic subjects.
    Bakke SS, Feng YZ, Nikolić N, Kase ET, Moro C, Stensrud C, Damlien L, Ludahl MO, Sandbu R, Solheim BM, Rustan AC, Hjelmesæth J, Thoresen GH, Aas V.
    PLoS One; 2015 Feb 30; 10(3):e0119556. PubMed ID: 25790476
    [Abstract] [Full Text] [Related]

  • 14. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.
    Gaster M.
    Biochem Biophys Res Commun; 2009 May 15; 382(4):766-70. PubMed ID: 19324004
    [Abstract] [Full Text] [Related]

  • 15. The dynamic of lipid oxidation in human myotubes.
    Gaster M.
    Biochim Biophys Acta; 2009 Jan 15; 1791(1):17-24. PubMed ID: 18952196
    [Abstract] [Full Text] [Related]

  • 16. FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.
    Bravard A, Lefai E, Meugnier E, Pesenti S, Disse E, Vouillarmet J, Peretti N, Rabasa-Lhoret R, Laville M, Vidal H, Rieusset J.
    Diabetes; 2011 Jan 15; 60(1):258-68. PubMed ID: 20943749
    [Abstract] [Full Text] [Related]

  • 17. Increased triacylglycerol - Fatty acid substrate cycling in human skeletal muscle cells exposed to eicosapentaenoic acid.
    Løvsletten NG, Bakke SS, Kase ET, Ouwens DM, Thoresen GH, Rustan AC.
    PLoS One; 2018 Jan 15; 13(11):e0208048. PubMed ID: 30496314
    [Abstract] [Full Text] [Related]

  • 18. Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.
    Thingholm TE, Bak S, Beck-Nielsen H, Jensen ON, Gaster M.
    Mol Cell Proteomics; 2011 Sep 15; 10(9):M110.006650. PubMed ID: 21697546
    [Abstract] [Full Text] [Related]

  • 19. Perilipin 3 Differentially Regulates Skeletal Muscle Lipid Oxidation in Active, Sedentary, and Type 2 Diabetic Males.
    Covington JD, Noland RC, Hebert RC, Masinter BS, Smith SR, Rustan AC, Ravussin E, Bajpeyi S.
    J Clin Endocrinol Metab; 2015 Oct 15; 100(10):3683-92. PubMed ID: 26171795
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.